Comparative hemodynamic effect of metrizamide and Renografin 76 in infants with congenital heart disease

Journal Article · Wed Jun 01 00:00:00 EDT 1983 · AJR, Am. J. Roentgenol.; (United States)

DOI:https://doi.org/10.2214/ajr.140.6.1097· OSTI ID:5775997

Baltaxe, H A ^[1]; Mooring, P; Kugler, J; Pinsky, W; Chu, W K

---

1. Univ. of California Davis Medical Center, Sacramento

Twenty patients under the age of 2 years with suspected congenital heart disease received alternately Renografin 76 and metrizamide for angiocardiography. The dose was 2.0 ml/kg per injection for both contrast media into the left ventricle. Metrizamide induced slightly lesser change in heart rate, peak systolic pressure, and peak end-diastolic pressures. Serum osmolality, hematocrit, and serum electrolytes were affected equally by the contrast media. Metrizamide was well tolerated by the neonates with congenital heart disease and its radiopacity was adequate for diagnostic purposes. At the doses administered, metrizamide does not seem to have any great advantage over Renografin 76 for angiocardiography in infants with severe congenital heart disease.

• OSTI ID: 5775997
• Journal Information: AJR, Am. J. Roentgenol.; (United States), Journal Name: AJR, Am. J. Roentgenol.; (United States) Vol. 140:6; ISSN AAJRD
• Country of Publication: United States
• Language: English

Related Subjects

550602* -- Medicine-- External Radiation in Diagnostics-- (1980-)
62 RADIOLOGY AND NUCLEAR MEDICINE
AGE GROUPS
AMIDES
CARDIOGRAPHY
CARDIOVASCULAR DISEASES
CHILDREN
COMPARATIVE EVALUATIONS
CONGENITAL DISEASES
CONTRAST MEDIA
DIAGNOSIS
DIAGNOSTIC TECHNIQUES
DISEASES
INFANTS
METRIZAMIDE
ORGANIC COMPOUNDS
ORGANIC NITROGEN COMPOUNDS
RADIOCARDIOGRAPHY